华芢生物科技（青岛）股份有限公司（香港联交所代码：2396）于2026年2月5日披露截至2026年1月31日的股份变动月报表。报告显示，公司已发行及注册股本在本月内无新增发行、购回或注销活动，股本结构维持稳定。
公司公告称，其注册股本包括83,022,145股H股和34,635,377股非上市股份，总额为117,657,522股。截至报告期末，H股和非上市股份的数量均与上月底持平，分别维持在83,022,145股和34,635,377股。报告亦显示公司当月未有任何股份期权或股权激励计划的新增授出或行使行为。
公司同时确认符合香港联交所《主板上市规则》有关公众持股量的要求，并遵守所有适用法律和监管规定。公告由公司联席公司秘书黄慧儿签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.